Discussion and Q&A - Amsterdam 2025 - ERS Respiratory Channel

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Amsterdam 2025 Discussion and Q&A

Should we use inhaled corticosteroids in children with bronchopulmonary dysplasia?

Chair(s): Lieuwe D.J. Bos, Anna Lavizzari

Session type: Pro-Con debate

Discussion and Q&A

EVENTS HOME

Replay

Previous presentation

Next presentation

Session content

Should we use inhaled corticosteroids in children with bronchopulmonary dysplasia? Pro

Sailesh Kotecha

Replay

Should we use inhaled corticosteroids in children with bronchopulmonary dysplasia? Con

Shannon Simpson

Replay

Slides

Discussion and Q&A

Replay

Session aims

to discuss the clinical benefits versus disadvantages of treating children with bronchopulmonary dysplasia with inhaled steroids; to discuss the criteria for selecting the population to be treated with inhaled steroids among children with bronchopulmonary dysplasia; to describe the criteria to assess treatment effectiveness; to compare and contrast different treatment regimens, including molecules, doses, intervals and durations.

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}